Acute Urinary Retention: Symptoms, Causes & Treatment

Acute urinary retention (AUR) is the sudden, painful, and complete inability to void urine despite a distended bladder. It constitutes a urological emergency requiring immediate urethral or suprapubic catheterization to decompress the bladder, relieve pain, and prevent renal injury from obstructive uropathy. AUR is distinguished from chronic urinary retention — painless, gradual incomplete emptying — by its acute onset and the presence of pain.

AUR primarily affects men, with a lifetime risk of 10% in men in their 70s and 30% in their 80s — predominantly driven by benign prostatic hyperplasia (BPH), the most common cause of AUR in males. Women are far less commonly affected (1:13 male-to-female ratio) — causes in women include urethral stricture, pelvic organ prolapse, and post-surgical neurological injury. Pathophysiologically, AUR arises from outflow obstruction (BPH, urethral stricture, clot retention) or from loss of detrusor muscle contractility (neurogenic, pharmacological, or post-surgical).

AUR can be precipitated by events that increase urethral tone or reduce detrusor contractility: alpha-agonist medications, anticholinergics, opioids, acute prostatic swelling from alcohol or infection, and spinal anesthesia. After catheterization and relief, post-obstructive diuresis must be monitored as the kidneys excrete retained sodium and water.

• Severe suprapubic pain and lower abdominal discomfort from bladder distension
• Intense, desperate urge to void with complete inability to pass any urine
• Palpable and/or visible suprapubic mass (distended bladder) on abdominal examination
• Agitation, diaphoresis, and autonomic distress from severe pain
• In prolonged retention: nausea, vomiting, hypertension (autonomic dysreflexia in spinal cord injury patients)

• Benign prostatic hyperplasia (BPH): the dominant cause in men — urethral compression by enlarged prostate
• Acute prostatitis or prostatic engorgement from alcohol, UTI, or constipation
• Bladder calculi or clot retention (post-hematuria) obstructing the bladder neck
• Urethral stricture from prior instrumentation, sexually transmitted infection (gonorrhea), or pelvic trauma
• Pharmacological: anticholinergics (oxybutynin, antihistamines, antidepressants), alpha-agonists (pseudoephedrine), opioids (particularly epidural)
• Neurogenic: spinal cord compression, multiple sclerosis, diabetic neuropathy, Parkinson's disease, post-spinal anesthesia
• Post-surgical (especially following pelvic or lumbar spinal surgery)

Clinical diagnosis: typical history + suprapubic dullness on percussion + palpable distended bladder. Bedside bladder ultrasound scan: confirms large residual urine volume (>300 mL confirms AUR; >150 mL is compatible). Catheterization is both diagnostic and therapeutic — insert urethral catheter; if unsuccessful (urethral stricture, prostatic obstruction), suprapubic catheter (SPC). After catheterization: urinalysis and culture, serum creatinine and electrolytes (assess renal impairment from chronic obstruction), PSA after inflammation subsides, prostate ultrasound, urodynamic studies for recurrent AUR.

Immediate bladder decompression: urethral Foley catheter — standard first-line; drain slowly if large volume (risk of post-obstructive diuresis and hematuria ex vacuo). If urethral catheterization fails (stricture, BPH): suprapubic catheter under ultrasound guidance. Alpha-blocker therapy (tamsulosin 0.4 mg or alfuzosin 10 mg) started before catheter removal: improves successful trial without catheter (TWOC) at 48–72 hours. For BPH-associated AUR: 5-alpha reductase inhibitors (finasteride) for long-term prevention; TURP (transurethral resection of the prostate) for recurrent AUR or failed TWOC. Treat precipitating cause: stop offending drugs, treat prostatitis (antibiotics), remove obstructing stone.

• Acute renal impairment from obstructive nephropathy in prolonged AUR — serum creatinine may be markedly elevated
• Post-obstructive diuresis: high-volume urine output after decompression (body excretes retained sodium, water, urea) — monitor electrolytes, replace cautiously if >200 mL/hour
• Catheter-associated UTI with prolonged urethral catheterization
• Detrusor muscle damage from repeated overdistension — may result in permanently impaired bladder contractility

• Early medical treatment of BPH with alpha-blockers and/or 5-alpha reductase inhibitors to reduce AUR risk
• Medication review in at-risk patients (BPH, neurological disease): avoid anticholinergics, nasal decongestants (alpha-agonists), and opioids when possible
• Post-surgical bladder monitoring: ensure adequate void before discharge from spinal or pelvic surgery
• Prompt treatment of UTI and constipation — both precipitate AUR in predisposed patients